ECSP034420A - Uso de cepas del parapoxvirus ovis frente a fibrosis de organos - Google Patents

Uso de cepas del parapoxvirus ovis frente a fibrosis de organos

Info

Publication number
ECSP034420A
ECSP034420A EC2003004420A ECSP034420A ECSP034420A EC SP034420 A ECSP034420 A EC SP034420A EC 2003004420 A EC2003004420 A EC 2003004420A EC SP034420 A ECSP034420 A EC SP034420A EC SP034420 A ECSP034420 A EC SP034420A
Authority
EC
Ecuador
Prior art keywords
vapes
organ fibrosis
fibrosis
parapoxvirus ovis
against organ
Prior art date
Application number
EC2003004420A
Other languages
English (en)
Spanish (es)
Inventor
Andreas Knorr
Dietrich Claudia Hirth
Olaf Weber
Gudrun Theiss
Angela Siegling
Tobias Schlapp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ECSP034420A publication Critical patent/ECSP034420A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24261—Methods of inactivation or attenuation
    • C12N2710/24264—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Addiction (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EC2003004420A 2000-07-11 2003-01-10 Uso de cepas del parapoxvirus ovis frente a fibrosis de organos ECSP034420A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10033581 2000-07-11

Publications (1)

Publication Number Publication Date
ECSP034420A true ECSP034420A (es) 2003-03-10

Family

ID=7648485

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004420A ECSP034420A (es) 2000-07-11 2003-01-10 Uso de cepas del parapoxvirus ovis frente a fibrosis de organos

Country Status (14)

Country Link
JP (2) JP5587950B2 (ko)
KR (1) KR100845643B1 (ko)
CN (1) CN101444539B (ko)
AT (1) ATE445413T1 (ko)
BR (1) BRPI0112411B8 (ko)
DE (2) DE10122233A1 (ko)
DK (1) DK1303302T3 (ko)
DO (1) DOP2001000210A (ko)
EC (1) ECSP034420A (ko)
ES (1) ES2332355T3 (ko)
PE (1) PE20020218A1 (ko)
PT (1) PT1303302E (ko)
SV (1) SV2002000527A (ko)
ZA (1) ZA200300276B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015111756A1 (de) * 2015-07-20 2017-01-26 Eberhard Karls Universität Tübingen Medizinische Fakultät Rekombinanter Orf-Virus-Vektor
US11077157B2 (en) 2016-02-16 2021-08-03 Osaka University Medicinal composition for treating fibrosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
KR100302994B1 (ko) * 1996-04-15 2001-11-30 안톤 마이어 약독화된비면역원성폭스바이러스또는파라폭스바이러스로부터멀티포텐트파라폭스면역유발인자의약제로서이용하는새로운적용

Also Published As

Publication number Publication date
CN101444539A (zh) 2009-06-03
ZA200300276B (en) 2004-04-13
DE50115181D1 (de) 2009-11-26
JP5587950B2 (ja) 2014-09-10
BR0112411A (pt) 2003-05-27
CN101444539B (zh) 2016-07-06
PE20020218A1 (es) 2002-05-19
KR100845643B1 (ko) 2008-07-10
BRPI0112411B8 (pt) 2021-05-25
SV2002000527A (es) 2002-10-24
DK1303302T3 (da) 2010-02-08
JP2014196329A (ja) 2014-10-16
DE10122233A1 (de) 2002-01-24
DOP2001000210A (es) 2002-12-15
ES2332355T3 (es) 2010-02-03
ATE445413T1 (de) 2009-10-15
KR20030019562A (ko) 2003-03-06
JP5950964B2 (ja) 2016-07-13
JP2012214492A (ja) 2012-11-08
PT1303302E (pt) 2009-11-11
BRPI0112411B1 (pt) 2018-02-27

Similar Documents

Publication Publication Date Title
DK0693281T3 (da) Farmaceutiske fluoxetinformuleringer
CA2283280A1 (en) Reovirus for the treatment of neoplasia
DK1418942T3 (da) Poxvirus-holdige sammensætninger og fremgangsmåde til fremstilling deraf
WO2003028692A8 (fr) Traitement de l'acne a l'aide d'acide oleanolique
SA519410993B1 (ar) النشاط المضاد للبكتيريا لأوليجو سكاريد من جالاكتو وزيليتول في العلاجات الجلدية
ECSP034420A (es) Uso de cepas del parapoxvirus ovis frente a fibrosis de organos
CA2504872A1 (en) Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
TR200200724T2 (tr) Cilde sürülebilen farmasötik bileşimlerin antimikrobik etkisinin arttırılması için yağlı asit/amino asit sabunlarının kullanımı
NO20013605L (no) Preparat for vorter
BR0316973A (pt) Uso de ácido docosahexanóico como substância ativa para o tratamento de lipodistrofia
EP1038529A3 (en) Agent for increasing chemokine production
MD2516B1 (en) Anti-inflammatory, antiseptic and antimycotic medicament in the form of gel
Vazquez How low can you go
ES2130069B1 (es) Preparacion farmaceutica con liberacion retardada del producto activo.
Fox Stop Trying Too Hard to Kill Bacteria
CN109419811A (zh) 一种治疗灰指甲的药物配方
Berger et al. Photo quiz: Diffuse papular eruption
BRPI0705224A2 (pt) uso do extrato de pau ferro (caesalpinia ferrea mart.) em formulações cosmésticas e farmacêuticas como agente despigmentante/clareador da pele
Nakashima et al. Mothproofing efficacy of wool-yarn treated with several kinds of medical herb against to cloth moth, Tinea Pellionella (L.)
GEU2001773Y (en) Medicinal Means of Antioxidant Activity
HN2001000153A (es) Uso de cepas de parafoxvirus ovis contra fibrosis de organos. solicitante: bayer aktiengesellschaft pais: leverkusen, alemania
GEP20002176B (en) Ointment “Bentastatin” for Treatment of Fungus Diseases of Skin and Mucous Membrane and Inflammatory Processes
AR031146A1 (es) Una composicion estable para el tratamiento topico de ulceras de la piel del tipo que corresponde a un gel o masa mucilaginosa y procedimiento para su preparacion
ES2103691A1 (es) Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales.
IT1274733B (it) Ceppo del genere lactobacillus di origine umana e suoi usi